Stifel Maintains Buy on Agilent Technologies, Raises Price Target to $180
Stifel analyst Daniel Arias maintains Agilent Technologies (NYSE:A) with a Buy and raises the price target from $170 to $180.
Read original at benzingaStocks · News reference
6 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner. Traders often
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 3, 2026, 5:35 PM
- Checked
- Aug 3, 2026, 5:35 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Citigroup Maintains Buy on Agilent Technologies, Raises Price Target to $190
Citigroup analyst Patrick Donnelly maintains Agilent Technologies (NYSE:A) with a Buy and raises the price target from $185 to $190.
Read original at benzingaJP Morgan Maintains Overweight on Agilent Technologies, Raises Price Target to $190
JP Morgan analyst Casey Woodring maintains Agilent Technologies (NYSE:A) with a Overweight and raises the price target from $180 to $190.
Read original at benzingaTD Cowen Maintains Buy on Agilent Technologies, Raises Price Target to $180
TD Cowen analyst Dan Brennan maintains Agilent Technologies (NYSE:A) with a Buy and raises the price target from $155 to $180.
Read original at benzingaObesity Drug Alert: Eli Lilly Study Shows Sustained Zepbound Treatment Reduces Hospital Visits, Medical Costs
New Eli Lilly study reveals that Zepbound significantly lowers monthly healthcare costs for older adults with overweight or obesity.
Read original at benzingaEli Lilly Stock Pulls Back After Hitting Record Highs Last Week
Eli Lilly and Co. shares are trading lower Wednesday, pulling back from last week's record high despite positive real-world data on Zepbound.
Read original at benzinga